Viewing Study NCT00051051


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2025-12-25 @ 9:43 PM
Study NCT ID: NCT00051051
Status: COMPLETED
Last Update Posted: 2007-05-04
First Post: 2003-01-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module